In 2007, Medtronic Inc. agreed to remove Sprint Fidelis leads associated with defibrillators off the market. The recall included model numbers 6930, 6931, 6948 and 6949.  Shortly after the technology entered the market in 2004, the manufacturer and the FDA began receiving complaints concerning the wires. However, the company withheld this information from the public. Other defibrillators also utilize the wires besides the device constructed by Medtronic.

Implanted Defibrillators

An estimated 268,000 patients have received implanted defibrillator devices utilizing Sprint Fidelis leads. At least 150,000 patients continue life with these implanted and possibly defective wires. The device, technically known as an implantable cardioverter defibrillator (ICD) or a cardiac resynchronization therapy defibrillator (CRT-D), contains the life saving technology within a metallic box the size of a matchbox. Physicians surgically insert the unit under the skin towards a patient’s shoulder area. Surgeons carefully thread fine silicon coated leads from the device, through a vein, positioning the wires into the heart. When a cardiac patient develops an unnatural rhythm or suffers cardiac arrest the defibrillator detects the anomaly and delivers an electrical current to the heart, correcting or restarting the rhythm.

Sprint Fidelis Lead Malfunction

Physicians soon discovered a disturbing trend in which wire fractures occurred after two years. Studies indicate the lead failure rate increases with the age of the wires. The lead malfunction causes the defibrillator to respond in one of three ways:

  • Device sends an audible signal alerting patients a system malfunction occurred.
  • System incorrectly evaluates disconnected signals as a symptom of dysrhythmia and initiates unnecessary electric current to the heart.
  • The disconnection drains the battery, rendering the defibrillator inactive, leaving patients unprotected.

Medtronic claims that 95.4% of the Sprint Fidelis leads had a life expectancy of three years and that the failure rate was 4.6%. Suspicions rose concerning the findings when information revealed researchers involved in the study received grants or consultation fees from Medtronic. Reputable medical facilities including the Mayo Clinic and the University of Rochester in New York found the failure rate to be at least twice that cited by Medtronic. Research conducted as recent as Feb. 2010 reveals failure rates exceeding 12%.

Patient Trauma and Surgical Revision

To date, over 100 deaths occurred because of lead malfunction. Fatalities resulted as patients received excessive amounts of unnecessary electrical current or defibrillators did not respond to a cardiac arrest. Patients receiving inappropriate electrical stimulation report the experience is extremely excruciating.

Cardiac surgeons are reluctant to remove defective leads due to increased surgical complications. Following lead insertion, the body naturally develops scar tissue around the wires. Physicians report this situation elevates surgical risks by over 19%. Lead extraction causes bleeding and tearing at the site of the scar tissue. In some instances, the bleeding proves to be fatal.

Contact Us

If you or someone you love was injured or killed because of a defective product such as the lead malfunctions in the Sprint Fidelis device, contact our office for a free evaluation. We will help you understand your rights and help you decide if you should pursue a claim for compensation because of the defective device.

Free Case Evaluation

More About CSS

  • woman holding bladder with a blue background
    Published On: April 25, 2025

    If you develop cancer or a condition associated with chemical straighteners, it’s important to know your legal options and how to proceed.

  • hands of an african american stylist applying hair relaxer cream to a female customer
    Published On: March 21, 2023

    There is substantial evidence that hair relaxers increase the likelihood of certain cancers. In addition to uterine cancer, there are also links between hair relaxer products and ovarian cancer.

  • pexels-helena-ije-2867899-scaled
    Published On: March 1, 2023

    If you have been diagnosed with cancer after regularly using hair relaxer products, you could have a claim for compensation against the manufacturer even if you have underlying health conditions.

  • Hairdresser relaxing the hair on an African woman head and also using comb to stretch and apply the relaxer cream through the hair
    Published On: February 21, 2023

    Proving legal damages after using hair relaxers can be challenging, but an experienced dangerous and defective product attorney can evaluate your claim to determine if you meet certain criteria to prove damages and recover compensation.

  • white talcum powder bottle spilled on a black surface
    Published On: December 20, 2022

    Understanding how to bring a talcum powder case starts with a free consultation—get the answers you need.

  • Two hands with talcum powder spilled all over them
    Published On: September 22, 2022

    Determining eligibility for a talcum powder lawsuit involves several factors, and guidance from our experienced attorneys can make all the difference.